Biomedical subjects
A Coates
Publications and source records attributed to A Coates.
Immune protection against experimental autoimmune encephalomyelitis: optimal conditions and analysis of mechanism.
Explore the source record for details and available documents.
Current status of immunotherapy.
Explore the source record for details and available documents.
Hymenolepis diminuta: active transport of alpha-aminoisobutyric acid by cysticercoid larvae.
Explore the source record for details and available documents.
Cyclophosphamide in pregnancy.
Explore the source record for details and available documents.
Quality of life studies of the Australian New Zealand Breast Cancer Trials Group: approaches to missing data.
The purpose of this paper is to describe the degree of compliance with quality of life measures in two clinical trials conducted by the Australian New Zealand Breast Cancer Trials Group comparing different chemotherapy policies for metastatic breast cancer. Quality of life was assessed by the patient using linear analogue scales and by the physician using the Spitzer QLI. Compliance was generally good, ranging from 66 per cent to 79 per cent in the earlier study, and from 63 per cent to 97 per cent in the later study. Compliance with physician rated quality of life was consistently slightly better than for patient self-assessment. The results of physician and patient assessments were generally consistent, but there was a systematic bias toward lower quality of life (as assessed by the physician) in patients who failed to comply with self-assessment. Our conclusions were that quality of life can be assessed in large scale multi-institution clinical trials in metastatic breast cancer. The results are important in assessing treatment comparisons. Missing data cannot be assumed to be similar to those available. Optimal assessment of quality of life therefore requires careful prospective attention to complete data collection.
Glutathione content of human malignant melanoma cell lines: correlation of flow cytometric and biochemical assays, and application to human tumour aspirates.
We measured the glutathione content of a panel of human malignant melanoma cell lines by flow cytometry after staining with mercury orange, using visible light (488 nm) excitation, and compared the values obtained with those measured biochemically using a modified Tietze assay. Glutathione levels were depleted by culturing cells with various concentrations of buthionine sulphoximine to provide a suitable spread of glutathione concentrations. The two assays showed good correlation (r = 0.93). We found a number of technical factors to be critically important. In particular, the conditions of staining, cell number, and method of mixing media, cells and stain were responsible for wide variations in fluorescence intensity. We applied the flow cytometric technique to cell suspensions obtained by fine needle aspiration biopsy of human malignant melanoma deposits, and observed a proportion of cells with high glutathione levels in many samples. The results confirm the feasibility of measuring glutathione content by visible light flow cytometry, and raise the possibility of monitoring glutathione content as an indicator of drug resistance in clinical therapy of human malignant melanoma.
Current status of clinical trials of therapeutic modalities for malignant melanoma in Australia.
Explore the source record for details and available documents.
Management of early breast cancer: an Australian consensus report. Clinical Oncological Society of Australia, the Australian-New Zealand Breast Cancer Trials Group, the Medical Oncology Group of Australia and the Breast Section, Royal Australasian College of Surgeons.
Explore the source record for details and available documents.